Evogene Q3 2021 Earnings Preview

04:17pm, Tuesday, 16'th Nov 2021 Seeking Alpha
Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to sha
Evogene Ltd.'s (NASDAQ:EVGN) (TASE: EVGN) wholly-owned subsidiary focused on developing medical cannabis products, Canonic Ltd.
REHOVOT, Israel, Sept. 14, 2021 /PRNewswire/ -- Evogene Ltd.
Evogene's Canonic Begins Selling High THC Cannabis In Israeli Medical Market

What Makes Evogene (EVGN) a New Buy Stock

01:45pm, Friday, 03'rd Sep 2021
Evogene (EVGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q2 2021 Results - Earnings Call Transcript
Biotechnology company Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) posted its financial results Wednesday for the first half and second quarter of 2021 along with a proclamation from the company's presid
REHOVOT, Israel, July 29, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several
Marijuana legalization is a hot topic & some penny stocks are benefiting in 2021. The post Best Penny Stocks To Buy Before Marijuana Legalization?
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
Canonic, a subsidiary of Evogene, will bring its unique cannabis products to the Israeli cannabis market in 2022. The company has been hard at work deciphering the cannabis genome and breeding special
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2021 Results - Earnings Call Transcript
Computational biology company Evogene Ltd. (NASDAQ:EVGN) reported Wednesday its first-quarter financial results with revenue of $333,000, compared to $75,000 in the same period of 2020.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE